Phathom Pharmaceuticals, Inc. Annual Return On Equity in % from 2018 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Phathom Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from 2018 to 2023.
  • Phathom Pharmaceuticals, Inc. Return On Equity for the quarter ending September 30, 2024 was 211 %, a 50.7% decline year-over-year.
  • Phathom Pharmaceuticals, Inc. annual Return On Equity for 2023 was 494 %, a 56.1% decline from 2022.
  • Phathom Pharmaceuticals, Inc. annual Return On Equity for 2022 was 1.13K %.
  • Phathom Pharmaceuticals, Inc. annual Return On Equity for 2021 was -122 %, a 76.6% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 494 -632 -56.1% Jan 1, 2023 Dec 31, 2023
2022 1.13K +1.25K Jan 1, 2022 Dec 31, 2022
2021 -122 -52.9 -76.6% Jan 1, 2021 Dec 31, 2021
2020 -69 -9K -101% Jan 1, 2020 Dec 31, 2020
2019 8.93K +8.75K +4843% Jan 1, 2019 Dec 31, 2019
2018 181 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.